1
项与 重组人促红素 (华润昂德) 相关的临床试验A Phase Ⅱ Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Polyethylene Glycol Recombinant Human Erythropoietin Injection (CHO Cell) in Optimal Dose and Administration Regimen for Maintenance Therapy in Patients With Regular Dialysis Renal Anemia.
The purpose of the study is to explore the optimal dose and administration of the experimental drug, and to evaluate the safety and efficacy of the drug in patients with renal anemia. Patients with renal anemia on regular dialysis treatment are expected to be enrolled in this study.
100 项与 重组人促红素 (华润昂德) 相关的临床结果
100 项与 重组人促红素 (华润昂德) 相关的转化医学
100 项与 重组人促红素 (华润昂德) 相关的专利(医药)
100 项与 重组人促红素 (华润昂德) 相关的药物交易